<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
MGC Pharmaceuticals Ltd delivered a year of ‘significant’ business growth for FY2021, with strong phytocannabanoid sales totalling around A$2 million – an increase of 69% from the previous year. In its annual report for the period ending June 30, 2021, sales of ArtemiC™ amounted to around A$705,000 with the balance relating to revenues derived from consulting services provided by wholly-owned subsidiaries MedicaNL and Medicinal Cannabis Clinics (MCC).
...read full article on Proactive Investors
